Marshall Mazepa

14PUBLICATIONS
29CO-AUTHORS
Computational physiologyTumour immunologyAutoimmunityHaematologyPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 07, 2026
Mortality Prediction in Immune TTP Remains Challenging Despite AI Advances.

|Feb 13, 2025
Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic Purpura.

Aaron B Boothby, Michael D Evans, Shangbin Yang

|Dec 03, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era.

Ayotola Fatola, Michael D Evans, Jenna Brown

|Dec 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.

Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson

|Sep 02, 2022
Caplacizumab for congenital thrombotic thrombocytopenic purpura.

Aaron Boothby, Marshall Mazepa

|Aug 18, 2022
Sounding the alarm for prophylaxis in hTTP.

Marshall Mazepa

Pageof 3

Frequent Collaborators

6 joint publications

Jay S Raval

4 joint publications

Michael D Evans

4 joint publications

Meera Sridharan

4 joint publications

Ming Yeong Lim